27/07/2012 1st Half 2012 Results
Sharp rise in Operating Profit
The new unit at Aulnay-sous-Bois, inaugurated today, enables the Group, specialized in contrast agents for medical imaging, to double its pharmaceutical production capacities in France in support of its international growth objectives. Read the press release
25/05/2012 Guerbet at ESGAR
from June 12 to 15 in Edinburgh, UK
21/05/2012 Guerbet joins G5 Health
G5 Health, a professional association that brings together major French health and life sciences companies, announced the addition of two new members, Guerbet, a global provider of contrast agents and imaging solutions for healthcare and Stallergenes, a world leader in the treatment of respiratory...
27/04/2012 Guerbet at ICR-JPR
Guerbet is participating in the International Congress of Radiology (ICR) and Jornada Paulista de Radiologia (JPR) from May 3 to 6 2012 in São Paulo, Brazil.
20/04/2012 2012 first-quarter revenue
Sales trends in line with new commercial strategy.
07/03/2012 2011 annual results
Strong and steady growth driven by Dotarem and Lipiodol.